{"id":"W2101864592","doi":"10.1186/1710-1492-10-33","title":"Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit","year":2014,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Ontario Ministry of Research and Innovation; Queen's University; Pfizer","keywords":"Fexofenadine; Pseudoephedrine; Nasal congestion; Medicine; Terfenadine; Crossover study; Placebo; Cetirizine; Antihistamine; Post-hoc analysis; Adverse effect; Histamine; Histamine H1 receptor; Pharmacology; Antagonist; Anesthesia; Internal medicine; Receptor; Surgery; Nose","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001156507,0.0003156733,0.001083878,0.0000673182,0.0004395357,0.00005933013,0.0001487649,0.0004870598,0.0005642684],"category_scores_gemma":[0.0004467605,0.0002148249,0.000440925,0.00007162063,0.001139462,0.00007771802,0.00009149965,0.0004768863,0.00003250419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003928762,"about_ca_system_score_gemma":0.00007495299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005011131,"about_ca_topic_score_gemma":0.0000395742,"domain_scores_codex":[0.9971264,0.0005911681,0.001111047,0.0005474897,0.0002209011,0.0004029663],"domain_scores_gemma":[0.9971653,0.001778213,0.0003958496,0.0004582802,0.00007351908,0.0001288017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847443,0.0006534359,0.00005265794,0.00000757208,0.001245139,0.00001308548,0.0002191085,0.00002514676,0.0007573417,0.006327173,0.0005777348,0.005377293],"study_design_scores_gemma":[0.8791402,0.004300102,0.0008522815,0.00005382428,0.0001399156,0.0001154395,0.0002798925,0.002614835,0.0001274096,0.0003292765,0.11177,0.0002768935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913836,0.0008696106,0.001646449,0.001681721,0.001358465,0.001751264,0.00001622466,0.00004584523,0.001246818],"genre_scores_gemma":[0.9914996,0.002447974,0.0004632227,0.001634528,0.0009961827,0.0001006338,0.0003793023,0.0000524332,0.002426113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1111922,"threshold_uncertainty_score":0.8760306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04731176846921797,"score_gpt":0.3286596520720131,"score_spread":0.2813478836027952,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}